Positive conclusion of a European DCP for approval of a tiotropium bromide-based maintenance treatment for those people living with COPD in a new inhaler (Zonda(R)) Teva Pharmaceutical Industries Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results